TaiGen Biotechnology
0
0
0
About
Overview
Steering Committee
Career
Management Team
Milestones
Board of Directors
About Us
TaiGen is a discovery-based and market-focused pharmaceutical company engaging in the development of novel therapeutics for infectious diseases and other indications with high degree of unmet medical needs.
R&D Center
Pipeline
R&D Progress
Antibiotic
Taigexyn®
Influenza Antiviral
TG-1000
HCV Antiviral
Furaprevir
Stem Cell Mobilizer
Burixafor
Research
R&D Center
TaiGen’s dedicated team of professional scientists perform cutting edge research in drug discovery to advance programs efficiently. Our pipeline of anti-infective & anti-inflammatory programs are the fruits of both internal research as well as in-licensed programs.
News
News
Investors
Investors
Financial Information
Material Information
Material Information
Shareholders' Information
Shareholders' Information
Corporate Governance
Investor FAQs
Investors
Communicating with investors, cultivating long-term investor relations and highlighting corporate’s value.
Business & Partnership
ESG
Contact Us
Home
繁中
Financial Information
Financial Reports
Monthly Revenues
2024 Monthly Revenues
Unit: NT$ thousands
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Month
Revenue
Revenue (accumulated)
YoY Change
July
2,483
134,034
22.19%
June
2,142
131,551
25.01%
May
114,597
129,409
30.82%
April
4,817
14,812
94.00%
March
2,582
9,995
73.43%
February
2,511
7,413
85.74%
January
4,902
4,902
73.89%
Home
Investors
Financial Information
Financial Reports